Home » Psychology news » Investigating plasma levels as biomarker for Alzheimer’s disease

Investigating plasma levels as biomarker for Alzheimer’s disease

April 18, 2016 by

The first detailed study of relationship between plasma levels of two amyloid beta peptides, cognitive function and the measures studying the size of brain, which shrinks with Alzheimer's disease.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>